Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
4.300
+0.090 (2.14%)
At close: Nov 13, 2026, 4:00 PM EST
4.360
+0.060 (1.40%)
After-hours: Nov 13, 2026, 7:25 PM EST
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $345.31 million as of November 13, 2026. It is the 16,942nd most valuable company in the world and the 3,011th biggest in the United States. Its market cap has increased by 26.28% in one year.
Market Cap
345.31M
Enterprise Value
154.32M
1-Year Change
26.28%
Global Rank
Country Rank
#3,011 United States
Category
ChartMarket Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $345.31M, a decrease of -82.18%. That is a compound annual growth rate of -24.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 345.31M | 23.81% |
| Dec 31, 2025 | 278.91M | -1.43% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Precision BioSciences | 349.26M |
| Faeth Therapeutics | 344.97M |
| AgomAb Therapeutics NV | 344.24M |
| ProKidney | 341.62M |
| Enanta Pharmaceuticals | 337.85M |
| Galectin Therapeutics | 331.80M |
| Benitec Biopharma | 330.34M |
| X4 Pharmaceuticals | 329.83M |